April Research Update: Major Depressive Disorder

Relapse in MDD is associated with morphologic brain changes; stopping exercise may increase depressive symptoms; and inflammatory biomarkers may predict which treatment-resistant MDD patients benefit from ECT.

Related Videos
Related Content

Positive Results for Lumateperone in Patients With Mixed Features in Major Depressive Disorder, Bipolar Depression

March 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Report Reveals More Than 50% of Americans Misuse At-Home Ketamine

March 13th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Objective Sleep Markers and Suicidal Behaviors

March 7th 2023

Views of US Religious Leaders on the Etiology and Treatment of Depression

February 22nd 2023

Positive Results for Lumateperone in Patients With Mixed Features in Major Depressive Disorder, Bipolar Depression

March 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Report Reveals More Than 50% of Americans Misuse At-Home Ketamine

March 13th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Objective Sleep Markers and Suicidal Behaviors

March 7th 2023

Views of US Religious Leaders on the Etiology and Treatment of Depression

February 22nd 2023

Positive Results for Lumateperone in Patients With Mixed Features in Major Depressive Disorder, Bipolar Depression

March 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Report Reveals More Than 50% of Americans Misuse At-Home Ketamine

March 13th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Objective Sleep Markers and Suicidal Behaviors

March 7th 2023

Views of US Religious Leaders on the Etiology and Treatment of Depression

February 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.